1. Armitage JO, Antman KH (1995) High-Dose Cancer Therapy, 2nd ed., Williams & Wilkins, Baltimore
2. Bamberg M, Schmoll HJ, Weißbach L (1995) Diagnostik und Therapie der Hodentumoren, Deutsches Ärzteblatt, 94
3. Blackstein M, Vogel CL, Ambinder R, Cowan J, Pearce P, Iglesia J (1997) Phase II study of gemcitabine in patients with metastatic breast cancer; Eur J of Cancer 33/8: 149, 664
4. Bonnandonna G (1995) Future developments in adjuvant systemic therapy of breast cancer. 5th International Con-ference on Adjuvant Therapy of Primary Breast Cancer. St. Gallen
5. Carmichael J, Hegg R, Firat D, Pawlicki M, Le Bras F, Danel P, Delgado FM (1997) Navelbine and fractionated dose doxorubicin improves first line advanced breast cancer chemotherapy. An overview of 3 phase II trials. Eur J of Cancer 33/8: 146, 649